Delivery Order SPE2DB20D3111-SPE2DB25FA9HA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,153.39 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,146.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing this order from its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp valued at $11,144.50 for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Jardiance 25 mg tablets (90-count units) valued at $46,168.05. This competitively awarded, firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by August 18, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,664.02 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract. The award was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,457.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,957.32 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count units) on August 10, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the...
- The Defense Logistics Agency awarded a delivery order valued at $18,140.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, carries no set-aside designation. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package. The contract is valued at $26,975.61 with a firm fixed price structure and an ultimate completion date of August 5, 2025. This delivery order carries no set-aside designation and will be performed at the contractor's...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9HADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,870.22 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count package) with a firm fixed price arrangement. This competitively awarded, non-set-aside contract was executed on September 8, 2025, with an ultimate completion date of September 9, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. As a prime vendor under this contract, AmerisourceBergen serves various federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, providing essential pharmaceutical commodities to support defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 9/8/25 |